Skip to main content
FinSpry Logo
FinSpry
PEPG logo
PEPG
(NASDAQ)
PepGen Inc.
$2.10-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

PepGen (PEPG) Company Profile

Complete business overview, executive team, trading details, and corporate information.

PepGen Inc.
PEPG•Nasdaq Stock Market•Healthcare•Biotechnology

About PepGen

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.

Company Information

SectorHealthcare
IndustryBiotechnology
CEOJames McArthur
Founded2018
IPO DateMay 6, 2022
Employees56
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Websitewww.pepgen.com
Phone781 797 0979
Address
321 Harrison Avenue, 8th Floor Boston, Massachusetts 02118 United States

Corporate Identifiers

CIK0001835597
CUSIP713317105
ISINUS7133171055
SIC2834

Leadership Team & Key Executives

Dr. James G. McArthur Ph.D.
President, Chief Executive Officer, Treasurer, Secretary and Director
Noel P. Donnelly M.B.A.
Chief Financial Officer
Joseph D. Vittiglio Esq., J.D.
Chief Business and Legal Officer and Secretary
Dr. Kasra Kasraian Ph.D.
Chief Technical Officer
Emiko Bryant
Senior Vice President of Human Resources and Administration
Dr. Hayley Parker Ph.D.
Senior Vice President of Global Regulatory Affairs and Quality
Dr. Paul D. Streck M.B.A., M.D.
Executive Vice President and Head of Research and Development
Pallavi Lonkar Ph.D.
Vice President and Head of Preclinical
Gregory Song
Executive Director and Head of Biometrics
Melissa Michaels
Executive Director and Head of Regulatory Affairs CMC